Jiangsu Aoyang Health Industry Co.ltd. / Fundamentals
Income statement
- Net revenue
€223.79M - Cost of goods sold
€192.39M - Gross profit
€31.40M - SG&A expenses
€4.18M - R&D expenses
€0.00 - EBITDA
€13.23M - D&A
€2.28M - EBIT
€7.46M - Interest expenses
€4.13M - EBT
€6.86M - Tax expenses
€2.68M - Net income
€4.14M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€44.89M - Changes in working capital
€0.00 - Operating cash flow
€45.05M - Capex
-€267.34K - Other investing cash flow
€6.70K - Net investing cash flow
€274.04K - Total cash dividends paid
-€3.47M - Issuance of common stock
€0.00 - Debt repayment
-€21.84M - Other financing cash flow
€191.14K - Net financing cash flow
-€25.11M - Foreign exchange effects
€850.41 - Net change in cash
-€1.19M - Cash at end of period
€26.93M - Free cash flow
€44.79M
Balance sheet
- Cash and cash equivalents
€55.02M - Cash and short-term investments
€55.02M - Total receivables
€49.92M - Inventory
€15.94M - Other current assets
€4.33M - Total current assets
€125.20M - Property, plant & equipment
€95.46M - Goodwill
€1.20M - Intangible assets
€7.41M - Long-term investments
€0.00 - Other non-current assets
€3.31M - Total non-current assets
€108.98M - Total assets
€234.18M - Accounts payable
€66.53M - Short-term debt
€76.87M - Other current liabilities
€50.38M - Total current liabilities
€195.70M - Long-term debt
€11.82M - Deferred tax liabilities
€12.09K - Other non-current liabilities
€8.30M - Total non-current liabilities
€21.10M - Total liabilities
€216.80M - Common stock
€91.11M - Retained earnings
-€226.18M - Other equity
€0.00 - Total equity
€17.38M - Total liabilities and shareholders' equity
€234.18M
Company information
- Market capitalization
€355.32M - Employees
2.2K - Enterprise Value
€3.87B
Company ratios
- Gross margin
-
14.0% Worse than peer group: 22.1% - EBITDA margin
-
5.9% Even with peer group: 8.9% - EBIT margin
-
3.3% Even with peer group: -0.7% - EBT margin
-
3.1% Even with peer group: 0.9% - Net margin
-
1.8% Even with peer group: 0.4% - ROE
-
23.8% Much better than peer group: -21.8% - ROA
-
1.8% Even with peer group: 1.5% - Asset turnover
-
95.6% Even with peer group: 92.0% - FCF margin
-
20.3% Much better than peer group: -12.4% - FCF yield
12.8% - Efficiency ratio
94.1% - Net sales per employee
-
€100.63K - Net income per employee
-
€1.86K